Your browser doesn't support javascript.
loading
The transcription factor c-Myb regulates CD8+ T cell stemness and antitumor immunity.
Gautam, Sanjivan; Fioravanti, Jessica; Zhu, Wei; Le Gall, John B; Brohawn, Philip; Lacey, Neal E; Hu, Jinhui; Hocker, James D; Hawk, Nga Voong; Kapoor, Veena; Telford, William G; Gurusamy, Devikala; Yu, Zhiya; Bhandoola, Avinash; Xue, Hai-Hui; Roychoudhuri, Rahul; Higgs, Brandon W; Restifo, Nicholas P; Bender, Timothy P; Ji, Yun; Gattinoni, Luca.
  • Gautam S; Experimental Transplantation and Immunology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.
  • Fioravanti J; Experimental Transplantation and Immunology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.
  • Zhu W; Department of Bioinformatics, Inova Translational Medicine Institute, Fairfax, VA, USA.
  • Le Gall JB; Experimental Transplantation and Immunology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.
  • Brohawn P; MedImmune, Gaithersburg, MD, USA.
  • Lacey NE; Experimental Transplantation and Immunology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.
  • Hu J; Experimental Transplantation and Immunology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.
  • Hocker JD; Experimental Transplantation and Immunology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.
  • Hawk NV; Experimental Transplantation and Immunology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.
  • Kapoor V; Experimental Transplantation and Immunology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.
  • Telford WG; Experimental Transplantation and Immunology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.
  • Gurusamy D; Surgery Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.
  • Yu Z; Surgery Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.
  • Bhandoola A; Laboratory of Genome Integrity, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.
  • Xue HH; Department of Microbiology, Carver College of Medicine, University of Iowa, Iowa City, IA, USA.
  • Roychoudhuri R; Laboratory of Lymphocyte Signaling and Development, Babraham Institute, Cambridge, UK.
  • Higgs BW; MedImmune, Gaithersburg, MD, USA.
  • Restifo NP; Surgery Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.
  • Bender TP; Department of Microbiology, University of Virginia, Charlottesville, VA, USA.
  • Ji Y; Beirne B. Carter Center for Immunology Research, University of Virginia, Charlottesville, VA, USA.
  • Gattinoni L; Experimental Transplantation and Immunology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.
Nat Immunol ; 20(3): 337-349, 2019 03.
Article en En | MEDLINE | ID: mdl-30778251
ABSTRACT
Stem cells are maintained by transcriptional programs that promote self-renewal and repress differentiation. Here, we found that the transcription factor c-Myb was essential for generating and maintaining stem cells in the CD8+ T cell memory compartment. Following viral infection, CD8+ T cells lacking Myb underwent terminal differentiation and generated fewer stem cell-like central memory cells than did Myb-sufficient T cells. c-Myb acted both as a transcriptional activator of Tcf7 (which encodes the transcription factor Tcf1) to enhance memory development and as a repressor of Zeb2 (which encodes the transcription factor Zeb2) to hinder effector differentiation. Domain-mutagenesis experiments revealed that the transactivation domain of c-Myb was necessary for restraining differentiation, whereas its negative regulatory domain was critical for cell survival. Myb overexpression enhanced CD8+ T cell memory formation, polyfunctionality and recall responses that promoted curative antitumor immunity after adoptive transfer. These findings identify c-Myb as a pivotal regulator of CD8+ T cell stemness and highlight its therapeutic potential.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Células Madre / Linfocitos T CD8-positivos / Proteínas Proto-Oncogénicas c-myb / Memoria Inmunológica / Neoplasias Experimentales Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Año: 2019 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Células Madre / Linfocitos T CD8-positivos / Proteínas Proto-Oncogénicas c-myb / Memoria Inmunológica / Neoplasias Experimentales Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Año: 2019 Tipo del documento: Article